A patient has had an overdose of an intravenous cholinergic drug. The nurse expects to administer which drug as an antidote?
Dobutamine
Atropine sulfate
Atenolol
Bethanechol
The Correct Answer is B
A. Dobutamine is a sympathomimetic drug used to increase cardiac output in conditions such as heart failure. It is not an antidote for cholinergic drug overdose.
B. Atropine sulfate is the antidote for cholinergic drug overdose. It acts as a competitive antagonist to acetylcholine at muscarinic receptors, counteracting the effects of excessive cholinergic stimulation.
C. Atenolol is a beta-blocker used to manage hypertension and certain cardiac conditions. It is not an antidote for cholinergic drug overdose.
D. Bethanechol is a cholinergic agonist used to stimulate bladder contractions in urinary retention. It is not an antidote for cholinergic drug overdose; in fact, it would exacerbate cholinergic effects.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is ["A","C","E"]
Explanation
A. Attention deficit hyperactivity disorder (ADHD) - Correct. CNS stimulants like
methylphenidate and amphetamine derivatives are commonly used to treat ADHD by improving attention, focus, and impulse control.
B. Panic attacks - Incorrect. CNS stimulants are not typically used to treat panic attacks.
Medications such as benzodiazepines or selective serotonin reuptake inhibitors (SSRIs) are more commonly used for panic disorder.
C. Narcolepsy - Correct. CNS stimulants are used to treat narcolepsy, a sleep disorder characterized by excessive daytime sleepiness and sudden attacks of sleep.
D. Neonatal apnea - Incorrect. CNS stimulants are not indicated for neonatal apnea.
Management of neonatal apnea usually involves supportive measures, respiratory support, and caffeine citrate as a respiratory stimulant.
E. Obesity - Correct. CNS stimulants like phentermine are sometimes used as adjuncts to diet and exercise for short-term management of obesity
Correct Answer is A
Explanation
A. Carbidopa prevents the breakdown of levodopa in the periphery, specifically in the gastrointestinal tract and peripheral tissues, allowing more levodopa to reach the brain and be converted to dopamine. This enhances the effectiveness of levodopa therapy in managing the symptoms of Parkinson's disease.
B. Carbidopa is not the biologic precursor of dopamine. It is a peripheral decarboxylase inhibitor that does not cross the blood-brain barrier.
C. Carbidopa does not directly allow for larger doses of levodopa to be given. However, by
inhibiting the peripheral breakdown of levodopa, it enhances the availability of levodopa to the central nervous system, potentially improving therapeutic efficacy.
D. While levodopa-carbidopa combination therapy may have fewer drug-food interactions compared to levodopa alone, the primary reason for combining these medications is to enhance the effectiveness of levodopa by preventing its peripheral breakdown.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.
